These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20934505)

  • 1. A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities.
    Pace TW; Heim CM
    Brain Behav Immun; 2011 Jan; 25(1):6-13. PubMed ID: 20934505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endocrine and inflammatory alterations in comorbid somatic diseases of post-traumatic stress disorder.
    Rohleder N; Karl A
    Minerva Endocrinol; 2006 Dec; 31(4):273-88. PubMed ID: 17213794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological underpinnings of health alterations in women with PTSD: a sex disparity.
    Gill JM; Szanton SL; Page GG
    Biol Res Nurs; 2005 Jul; 7(1):44-54. PubMed ID: 15920002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies.
    Boscarino JA
    Ann N Y Acad Sci; 2004 Dec; 1032():141-53. PubMed ID: 15677401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating lymphocyte subsets, natural killer cell cytotoxicity, and components of hypothalamic-pituitary-adrenal axis in Croatian war veterans with posttraumatic stress disorder: cross-sectional study.
    Vidović A; Vilibić M; Sabioncello A; Gotovac K; Rabatić S; Folnegović-Smalc V; Dekaris D
    Croat Med J; 2007 Apr; 48(2):198-206. PubMed ID: 17436384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model of suicidal behavior in war veterans with posttraumatic mood disorder.
    Sher L
    Med Hypotheses; 2009 Aug; 73(2):215-9. PubMed ID: 19327892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell cytotoxicity and lymphocyte perforin expression in veterans with posttraumatic stress disorder.
    Gotovac K; Vidović A; Vukusić H; Krcmar T; Sabioncello A; Rabatić S; Dekaris D
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):597-604. PubMed ID: 20184935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Post-traumatic stress, post-traumatic depression and major depressive episode: literature].
    Ducrocq F; Vaiva G; Cottencin O; Molenda S; Bailly D
    Encephale; 2001; 27(2):159-68. PubMed ID: 11407268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated assessments of endocrine- and immune-related changes in posttraumatic stress disorder.
    Vidović A; Gotovac K; Vilibić M; Sabioncello A; Jovanović T; Rabatić S; Folnegović-Šmalć V; Dekaris D
    Neuroimmunomodulation; 2011; 18(4):199-211. PubMed ID: 21335985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking the neuroendocrinology of post-traumatic stress disorder with recent neuroanatomic findings.
    Yehuda R
    Semin Clin Neuropsychiatry; 1999 Oct; 4(4):256-65. PubMed ID: 10553031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte glucocorticoid receptor expression and immunoregulation in veterans with and without post-traumatic stress disorder.
    de Kloet CS; Vermetten E; Bikker A; Meulman E; Geuze E; Kavelaars A; Westenberg HG; Heijnen CJ
    Mol Psychiatry; 2007 May; 12(5):443-53. PubMed ID: 17245326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTSD is associated with an excess of inflammatory immune activities.
    Gill JM; Saligan L; Woods S; Page G
    Perspect Psychiatr Care; 2009 Oct; 45(4):262-77. PubMed ID: 19780999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune function in PTSD.
    Altemus M; Dhabhar FS; Yang R
    Ann N Y Acad Sci; 2006 Jul; 1071():167-83. PubMed ID: 16891569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between neuroimmunoendocrine systems during post-traumatic stress disorder: a minireview.
    Bauer ME; Wieck A; Lopes RP; Teixeira AL; Grassi-Oliveira R
    Neuroimmunomodulation; 2010; 17(3):192-5. PubMed ID: 20134200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review.
    de Kloet CS; Vermetten E; Geuze E; Kavelaars A; Heijnen CJ; Westenberg HG
    J Psychiatr Res; 2006 Sep; 40(6):550-67. PubMed ID: 16214171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttraumatic stress disorder and physical comorbidity among female children and adolescents: results from service-use data.
    Seng JS; Graham-Bermann SA; Clark MK; McCarthy AM; Ronis DL
    Pediatrics; 2005 Dec; 116(6):e767-76. PubMed ID: 16322133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk and resilience in posttraumatic stress disorder.
    Yehuda R
    J Clin Psychiatry; 2004; 65 Suppl 1():29-36. PubMed ID: 14728094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbid anxiety disorders in civilians seeking treatment for posttraumatic stress disorder.
    Zayfert C; Becker CB; Unger DL; Shearer DK
    J Trauma Stress; 2002 Feb; 15(1):31-8. PubMed ID: 11936720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory biomarkers in patients with posttraumatic stress disorder caused by myocardial infarction and the role of depressive symptoms.
    von Känel R; Begré S; Abbas CC; Saner H; Gander ML; Schmid JP
    Neuroimmunomodulation; 2010; 17(1):39-46. PubMed ID: 19816056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.